CD107a+ (LAMP-1) Cytotoxic CD8+ T-Cells in Lupus Nephritis Patients
暂无分享,去创建一个
A. Kribben | K. Amann | O. Witzke | K. Lang | W. Abdulahad | B. Wilde | S. Dolff | B. Tyczynski | A. Wiechmann
[1] D. U. Nagy,et al. Investigation of the PD-1 and PD-L1 Immune Checkpoint Molecules Throughout Healthy Human Pregnancy and in Nonpregnant Women , 2020, Journal of clinical medicine.
[2] A. Kribben,et al. BTLA Expression on Th1, Th2 and Th17 Effector T-Cells of Patients with Systemic Lupus Erythematosus Is Associated with Active Disease , 2019, International journal of molecular sciences.
[3] O. Witzke,et al. Th17 cells in renal inflammation and autoimmunity. , 2019, Autoimmunity reviews.
[4] Andreas Radbruch,et al. Mapping urinary chemokines in human lupus nephritis: Potentially redundant pathways recruit CD4+ and CD8+ T cells and macrophages , 2017, European journal of immunology.
[5] G. Tsokos,et al. Selective Loss of Signaling Lymphocytic Activation Molecule Family Member 4–Positive CD8+ T Cells Contributes to the Decreased Cytotoxic Cell Activity in Systemic Lupus Erythematosus , 2016, Arthritis & rheumatology.
[6] K. McFann,et al. Podocytes Degrade Endocytosed Albumin Primarily in Lysosomes , 2014, PloS one.
[7] A. Karras,et al. Tissue-Specific Microvascular Endothelial Cells Show Distinct Capacity To Activate NK Cells: Implications for the Pathophysiology of Granulomatosis with Polyangiitis , 2014, The Journal of Immunology.
[8] P. Saftig,et al. Surface CD107a/LAMP-1 protects natural killer cells from degranulation-associated damage. , 2013, Blood.
[9] J. Coligan,et al. LAMP1/CD107a is required for efficient perforin delivery to lytic granules and NK-cell cytotoxicity. , 2013, Blood.
[10] M. V. van Dijk,et al. Urinary CD8+ T-cell counts discriminate between active and inactive lupus nephritis , 2013, Arthritis Research & Therapy.
[11] M. Bijl,et al. Treatment of lupus nephritis , 2010, Expert review of clinical immunology.
[12] C. Kallenberg,et al. Increased expression of costimulatory markers CD134 and CD80 on interleukin-17 producing T cells in patients with systemic lupus erythematosus , 2010, Arthritis research & therapy.
[13] M. V. van Dijk,et al. Urinary T cells in active lupus nephritis show an effector memory phenotype , 2010, Annals of the rheumatic diseases.
[14] C. Combe,et al. Predominance of CD8+ T lymphocytes among periglomerular infiltrating cells and link to the prognosis of class III and class IV lupus nephritis. , 2007, Arthritis and rheumatism.
[15] H. Tsuji,et al. Disruptive effect of chloroquine on lysosomes in cultured rat hepatocytes. , 2005, Biological & pharmaceutical bulletin.
[16] Lee Hebert,et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. , 2004, Kidney international.
[17] M. Hochberg,et al. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.
[18] R. Holcombe,et al. Lysosome-associated membrane proteins h-LAMP1 (CD107a) and h-LAMP2 (CD107b) are activation-dependent cell surface glycoproteins in human peripheral blood mononuclear cells which mediate cell adhesion to vascular endothelium. , 1996, Cellular immunology.
[19] R. Holcombe,et al. Correlation of Serum Interleukin-8 and Cell Surface Lysosome-associated Membrane Protein with Clinical Disease Activity in Systemic Lupus Erythematosus , 1994 .
[20] D. Boumpas,et al. Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data. , 1994, Kidney international.
[21] M. Liang,et al. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. , 1989, Arthritis and rheumatism.
[22] V. D’Agati,et al. Monoclonal antibody identification of infiltrating mononuclear leukocytes in lupus nephritis. , 1986, Kidney international.
[23] A. Elia,et al. Expression of NKG2D and CD107 in CD8(+) effector memory lymphocytes in Churg-Strauss syndrome. , 2012, Clinical and experimental rheumatology.
[24] E. Aktas,et al. Relationship between CD107a expression and cytotoxic activity. , 2009, Cellular immunology.
[25] J. Moreau,et al. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus. , 2005, Arthritis and rheumatism.
[26] R. Holcombe,et al. Correlation of serum interleukin-8 and cell surface lysosome-associated membrane protein expression with clinical disease activity in systemic lupus erythematosus. , 1994, Lupus.